FrancophonIA/ELRC3.0 huggingface dataset:
English: • acid reflux
Slovenian: • refluks kisline
English: Phenylbutazone, sodium salicylate, and aspirin may displace etoposide from plasma protein binding.
Slovenian: Fenilbutazon, natrijev salicilat in acetilsalicilna kislina lahko izpodrineta etopozid, vezan na plazemske beljakovine.
English: Total body clearance values range from 33 to 48 mL/min or 16 to 36 mL/min/m2 and, like the terminal elimination half-life, are independent of dose over a range 100 to 600 mg/m2.
Slovenian: Celotni telesni očistek etopozida sega od 33 do 48 ml/min ali od 16 do 36 ml/min/m2 in je, podobno kot končni razpolovni čas izločanja, neodvisen od odmerka v razponu od 100 do 600 mg/m2.
English: Infections and infestations not known infection
Slovenian: Infekcijske in parazitske bolezni neznana okužba
English: Respiratory, thoracic and mediastinal disorders rare interstitial pneumonitis, pulmonary fibrosis
Slovenian: Bolezni dihal, prsnega koša in mediastinalnega prostora redki intersticijski pnevmonitis, pljučna fibroza
English: Nervous system disorders common dizziness uncommon neuropathy peripheral rare cortical blindness transient, neurotoxicities (e.g., somnolence and fatigue), optic neuritis, seizure**
Slovenian: Bolezni živčevja pogosti omotica občasni periferna nevropatija redki prehodna kortikalna slepota, nevrotoksičnost (npr. somnolenca in utrujenost), optični nevritis, konvulzije**
English: Since etoposide and its metabolites are not dialyzable, it can be administered pre- and post-haemodialysis (see section 4.9).
Slovenian: Ker se etopozid in njegovi presnovki ne dializirajo, ga je mogoče dajati pred hemodializo in po njej (glejte poglavje 4.9).
English: There are no or limited amount of data from the use of etoposide in pregnant women.
Slovenian: Nosečnost Podatkov o uporabi etopozid pri nosečnicah ni oziroma so omejeni.
English: Male patients treated with VEPESID and associated names are advised not to father a child during treatment and for up to 6 months after treatment.
Slovenian: Bolnikom, zdravljenim z zdravilom VEPESID in povezana imena, je treba svetovati, naj med zdravljenjem in še 6 mesecev po zaključku zdravljenja ne spočnejo otroka.
English: Subsequent dosing in moderate and severe renal impairment should be based on patient tolerance and clinical effect (see section 4.4).
Slovenian: Naslednji odmerki pri zmerni in hudi okvari ledvic so odvisni od bolnikovega prenašanja etopozida in kliničnega učinka (glejte poglavje 4.4).
English: Within-patient variability in exposure (i.e. between cycles) is larger with oral administration than after intravenous administration.
Slovenian: Razlike v izpostavljenosti pri bolnikih (tj. med cikli) so pri peroralnem dajanju večje kot pri intravenskem dajanju.
English: In adult cancer patients with liver dysfunction, total body clearance of etoposide is not reduced.
Slovenian: Pri odraslih bolnikih z rakom in okvarjeno jetrno funkcijo celotni telesni očistek etopozida ni zmanjšan.
English: Small cell lung cancer
Slovenian: Drobnocelični pljučni rak
English: Low serum albumin is associated with increased exposure to etoposide.
Slovenian: Nizke vrednostmi serumskih albuminov so povezane s povečano izpostavljenostjo etopozidu.
English: Secondary leukaemia
Slovenian: Sekundarna levkemija
English: Anaphylactic reactions manifested by chills, fever, tachycardia, bronchospasm, dyspnoea, and hypotension which can be fatal can occur with the initial dose of etoposide.
Slovenian: Anafilaktične reakcije, ki se kažejo z mrzlico, zvišano telesno temperaturo, tahikardijo, bronhospazmom, dispnejo in hipotenzijo in so lahko smrtne, se lahko pojavijo ob začetnem odmerku etopozida.
English: Effects of other drugs on the pharmacokinetics of etoposide
Slovenian: Učinki drugih zdravil na farmakokinetiko etopozida
English: On intravenous administration, the disposition of etoposide is best described as a biphasic process with a distribution half-life of about 1.5 hours and terminal elimination half-life ranging from 4 to 11 hours.
Slovenian: Po intravenskem dajanju se etopozid dvofazno razporedi po telesu; razpolovni čas porazdelitve je okoli 1,5 ure, končni razpolovni čas izločanja pa med 4 in 11 urami.
English: nausea and vomiting common diarrhoea, mucositis (including stomatitis and esophagitis)
Slovenian: navzea in bruhanje pogosti diareja, mukozitis (vključno s stomatitisom in ezofagitisom)
English: Co-administration of warfarin and etoposide may result in elevated international normalized ratio (INR).
Slovenian: Sočasno zdravljenje z varfarinom lahko povzroči povečane vrednosti INR (internacionalno normalizirano razmerje).
English: Patients with impaired renal function receiving etoposide have exhibited reduced total body clearance, increased AUC and higher steady state volume of distribution (see section 4.2).
Slovenian: Pri bolnikih z ledvično okvaro se zmanjša celotni telesni očistek etopozida, poveča se AUC in zmanjša volumen porazdelitve v stanju dinamičnega ravnovesja (glejte poglavje 4.2).
English: If clinically significant hypertension occurs in patients receiving etoposide, appropriate supportive therapy should be initiated.
Slovenian: Če se pri bolnikih, ki prejemajo etopozid, pojavi klinično pomembno zvišanje krvnega tlaka je potrebno uvesti ustrezno zdravljenje.
English: Capsule content
Slovenian: Ovojnica kapsule
English: SPECIAL STORAGE CONDITIONS [To be completed nationally]
Slovenian: POSEBNA NAVODILA ZA SHRANJEVANJE [Izpolni država članica.]
English: In patients with impaired renal function, the following initial dose modification should be considered based on measured creatinine clearance.
Slovenian: Pri bolnikih z okvarjenim delovanjem ledvic je treba začetni odmerek prilagoditi glede na izmerjeno vrednost očistka kreatinina.
English: What you need to know before you take VEPESID and associated names
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo VEPESID in povezana imena
English: The dose of VEPESID and associated names capsules is based on the recommended intravenous dose taking into account the dose-dependent bioavailability of VEPESID and associated names capsules.
Slovenian: Odmerek kapsul zdravila VEPESID in povezana imena je izračunan iz priporočenih intravenskih odmerkov ob upoštevanju podatkov o biološki uporabnosti kapsul zdravila VEPESID in povezana imena, ki je odvisna od odmerka.
English: High dose ciclosporin, resulting in plasma concentrations above 2000 ng/mL, administered with oral etoposide has led to an 80% increase in etoposide exposure (AUC) with a 38% decrease in total body clearance of etoposide compared to etoposide alone.
Slovenian: Sočasno dajanje visokih odmerkov ciklosporina, ki povzroči plazemske koncentracije nad 2.000ng/ml, in peroralnega etopozida poveča izpostavljenost etopozidu za 80 % (AUC) in zmanjša celotni telesni očistek etopozida za 38 % v primerjavi z dajanjem samega etopozida.
English: The mean renal clearance of etoposide is 7 to 10 mL/min/m2 or about 35% of the total body clearance over a dose range of 80 to 600 mg/m2.
Slovenian: Povprečni ledvični očistek etopozida je 7 do 10 ml/min/m2 ali približno 35 % skupnega telesnega očistka v razponu odmerkov od 80 do 600 mg/m2.
English: - The other ingredients are: citric acid, anhydrous (E330), glycerol (85 per cent) (E422), macrogol 400 (E1521) and water.
Slovenian: - Druge sestavine zdravila so: brezvodna citronska kislina (E330), glicerol (85-odstotni) (E422), makrogol 400 (E1521) in voda.
English: Live vaccines are contraindicated in immunosuppressed patients (see section 4.3).
Slovenian: Cepljenje z živimi cepivi je kontraindicirano pri bolnikih z oslabljenim imunskim sistemom (glejte poglavje 4.3).
English: • tumour lysis syndrome (complications of substances released from treated cancer cells entering the blood)
Slovenian: • krvavitev sproščanju snovi iz zdravljenih rakavih celic v krvni obtok)
English: PHARMACEUTICAL FORM AND CONTENTS [To be completed nationally]
Slovenian: FARMACEVTSKA OBLIKA IN VSEBINA [Izpolni država članica.]
English: If you have any further questions on the use of this medicine, ask your Doctor or Pharmacist.
Slovenian: Če imate dodatna vprašanja o uporabi zdravila, se posvetujte z zdravnikom ali s farmacevtom.
English: VEPESID and associated names capsules should only be administered and monitored under the supervision of a qualified physician experienced in the use of anti-neoplastic medicinal products (see section 4.4).
Slovenian: Zdravljenje s kapsulami zdravila VEPESID in povezana imena lahko uvede in nadzira le usposobljen zdravnik, ki ima izkušnje z uporabo zdravil za zdravljenje novotvorb (glejte poglavje 4.4).
English: Cardiac disorders common arrythmia, myocardial infarction
Slovenian: Srčne bolezni pogosti aritmija, miokardni infarkt
English: There is increased risk of fatal systemic vaccinal disease with the use of yellow fever vaccine.
Slovenian: Pri cepljenju s cepivom proti rumeni mrzlici obstaja povečano tveganje za razvoj sistemske bolezni, povezane s cepljenjem, ki je lahko smrtna.
English: Skin and subcutaneous tissue disorders very common alopecia, pigmentation common pruritus, rash, urticaria rare radiation recall dermatitis, StevensJohnsons syndrome, toxic epidermal necrolysis
Slovenian: Bolezni kože in podkožja zelo pogosti alopecija, pigmentacija pogosti pruritus, izpuščaj, urtikarija redki dermatitis po obsevanju, StevenJohnsonov sindrom, toksična epidermalna nekroliza
English: • increased liver enzymes
Slovenian: • zvišani jetrni encimi
English: The following haematological parameters should be measured at the start of therapy and prior to each subsequent dose of VEPESID and associated names: platelet count, haemoglobin, white blood cell count and differential.
Slovenian: Pred začetkom zdravljenja in pred vsakim naslednjim odmerkom zdravila VEPESID in povezana imena je treba izmeriti naslednje hematološke parametre: število trombocitov, hemoglobin, število levkocitov in diferencialno krvno sliko.
English: Non-Hodgkin's lymphoma
Slovenian: Ne-Hodgkinov limfom
English: The hydroxyacid metabolite [4' dimethyl-epipodophyllic acid-9-(4,6 0-ethylidene-β-Dglucopyranoside)], formed by opening of the lactone ring, is found in the urine of adults and children.
Slovenian: V urinu odraslih in otrok najdemo hidroksikislinski presnovek [4'-dimetil-epipodofilna kislina-9-(4,60-etiliden-β-D-glukopiranozid)], ki nastane z odprtjem laktonskega obroča.
English: MARKETING AUTHORISATION NUMBER(S) [To be completed nationally]
Slovenian: ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET [Izpolni država članica.]
English: Ovarian cancer
Slovenian: - rak jajčnikov
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 50 mg etoposide
Slovenian: KAKOVOSTNA IN KOLIČINSKA SESTAVA Ena kapsula vsebuje 50 mg etopozida.
English: Tumour lysis syndrome (sometimes fatal) has been reported following the use of etoposide in association with other chemotherapeutic drugs (see section 4.4).
Slovenian: O sindromu tumorske lize (ki je bil včasih smrten) so poročali po uporabi etopozida skupaj z drugimi kemoterapevtiki (glejte poglavje 4.4).
English: A 100 mg oral dose would be comparable to a 75 mg intravenous dose; a 400 mg oral dose would be comparable to a 200 mg intravenous dose.
Slovenian: Peroralni odmerek 100 mg je primerljiv s 75 mg intravenskim odmerkom, peroralni odmerek 400 mg pa z 200 mg intravenskim odmerkom.
English: PHARMACEUTICAL FORM [To be completed nationally]
Slovenian: FARMACEVTSKA OBLIKA [Izpolni država članica.]
English: Hepatobiliary disorders very common hepatotoxicity not known alanine aminotransferase increased, alkaline phosphatase increased, aspartate amino transferase increased, bilirubin increased
Slovenian: Bolezni jeter, žolčnika in žolčevodov zelo pogosti hepatotoksičnost neznana zvišana alanin-aminotransferaza, zvišana alkalna fosfataza, zvišana aspartataminotransferaza, zvišan bilirubin
English: - if you are taking any anthracyclines (a group of medicines used to treat cancer).
Slovenian: - Če jemljete kateri koli antraciklin (skupina zdravil za zdravljenje raka).
English: How to store VEPESID and associated names Contents of the pack and other information
Slovenian: Shranjevanje zdravila VEPESID in povezana imena Vsebina pakiranja in dodatne informacije
English: Concomitant use of yellow fever vaccine or other live vaccines is contraindicated in immunosuppressed patients (see section 4.5).
Slovenian: Sočasno cepljenje proti rumeni mrzlici ali cepljenje z drugimi živimi cepivi je kontraindicirano pri bolnikih z oslabljenim imunskim sistemom (glejte poglavje 4.5).
English: Etoposide is mutagenic in mammalian cells.
Slovenian: Etopozid ima mutagen učinek na sesalske celice.
English: Severe myelosuppression with resulting infection or haemorrhage may occur.
Slovenian: Po uporabi se lahko pojavi huda mielosupresija, katere posledica so lahko okužbe ali krvavitve.
English: Anaemia, leucopenia, and thrombocytopenia were observed in rats and mice, while dogs had mild reversible deterioration of liver and kidney functions.
Slovenian: Pri podganah in miših so opazili anemijo, levkopenijo in trombocitopenijo, pri psih pa blago, reverzibilno poslabšanje delovanja jeter in ledvic.
English: Physicians should be aware of the possible occurrence of an anaphylactic reaction with VEPESID and associated names, manifested by chills, pyrexia, tachycardia, bronchospasm, dyspnoea and hypotension, which can be fatal.
Slovenian: Zdravnik mora biti pozoren na možnost anafilaktične reakcije pri zdravljenju z zdravilom VEPESID in povezana imena, ki se kaže kot mrzlica, zvišana telesna temperatura, tahikardija, bronhospazem, dispneja in hipotenzija, in se lahko konča s smrtjo.
English: VEPESID and associated names capsules contain sodium propyl parahydroxybenzoate and sodium ethyl parahydroxybenzoate which may cause allergic reactions (possibly delayed).
Slovenian: Kapsule zdravila VEPESID in povezana imena vsebujejo natrijev propilparahidroksibenzoat in natrijev etilparahidroksibenzoat, ki lahko povzročita alergijske reakcije (lahko zapoznele).
English: INSTRUCTIONS ON USE [To be completed nationally]
Slovenian: NAVODILA ZA UPORABO [Izpolni država članica.]
English: - if you are being treated with cisplatin (a medicine used to treat cancer).
Slovenian: - Če se zdravite s cisplatinom (zdravilom za zdravljenje raka).
English: Unbound fraction of etoposide correlates significantly with bilirubin in cancer patients.
Slovenian: Nevezan delež etopozida korelira pri rakavih bolnikih z bilirubinom.
English: This abnormality has also been seen in patients developing secondary leukaemia after being treated with chemotherapy regimens not containing epipodophyllotoxins and in leukaemia occurring de novo.
Slovenian: Enako okvaro so opazili tudi pri bolnikih s sekundarno levkemijo, ki so se zdravili s kemoterapevtskimi režimi zdravljenja, ki niso vključevali epipodofilotoksinov in pa pri bolnikih, ki so za levkemijo zboleli na novo.
English: Hodgkin's lymphoma
Slovenian: Hodgkinov limfom
English: The doses after the initial dose should be adjusted if neutrophil count is below 500 cells/mm for more than 5 days.
Slovenian: Odmerke, ki sledijo začetnemu odmerku, je treba prilagoditi, če je število nevtrofilcev pod 500/mm3 več kot 5 dni.
English: • serious reactions of the skin and/or mucous membranes which may include painful blisters and fever, including extensive detachment of the skin (Stevens-Johnson syndrome and toxic epidermal necrolysis)
Slovenian: • resne reakcije na koži in/ali sluznicah, ki lahko vključujejo boleče mehurje in vročino, vključno s hudim luščenjem kože
English: The capsule shell contain gelatin (E441), glycerol (85 per cent) (E422), red iron oxide (E172), sodium ethyl parahydroxybenzoate (E215), sodium propyl parahydroxybenzoate (E217) and titanium dioxide (E171).
Slovenian: Ovojnica kapsule vsebuje želatino (E441), glicerol (85odstotni) (E422), rdeči železov oksid (E172), natrijev etilparahidroksibenzoat (E215), natrijev propilparahidroksibenzoat (E217) in titanov dioksid (E171).
English: Haematological parameters should be measured and dose adjustments in subsequent cycles considered based on haematological toxicity and clinical effect in moderate and severe renal impaired patients.
Slovenian: Pri bolnikih z zmerno in hudo okvaro ledvic je treba izmeriti hematološke parametre in razmisliti o prilagoditvah odmerka v nadaljnjih ciklih glede na hematološko toksičnost in klinični učinek.
English: The usual dose of VEPESID and associated names administered orally is 100 to 200 mg/m2/day on days 1 to 5 or 200 mg/m2/day on days 1, 3 and 5 every 3 to 4 weeks in combination with other drugs approved for use in the disease to be treated.
Slovenian: Običajni odmerek zdravila VEPESID in povezana imena za peroralno dajanje je 100 do 200 mg/m2/dan, od 1. do 5. dne ali 200 mg/m2/dan, 1., 3. in 5. dan vsake 3. do 4 tedne v kombinaciji z drugimi zdravili, odobrenimi za uporabo pri zdravljeni bolezni.
English: Very common side effects (affecting more than 1 in 10 people)
Slovenian: Zelo pogosti neželeni učinki (pojavijo se lahko pri več kot 1 od 10 bolnikov):
English: As etoposide may decrease male fertility, preservation of sperm may be considered for the purpose of later fatherhood.
Slovenian: Etopozid lahko zmanjša plodnost pri moških, zato je, zaradi možnosti kasnejšega očetovstva, priporočljiv odvzem in hramba sperme.
English: Given the mutagenic potential of etoposide, an effective contraceptive is required for both male and female patients during treatment and up to 6 months after ending treatment (see section 4.4).
Slovenian: Glede na možno mutageno delovanje etopozida, morajo tako ženske kot moški uporabljati učinkovito kontracepcijo med zdravljenjem in do 6 mesecev po njem (glejte poglavje 4.4).
English: Blood and lymphatic system disorders very common anaemia , leucopenia, myelosuppression*, neutropenia, thrombocytopenia
Slovenian: Bolezni krvi in limfatičnega sistema zelo pogosti anemija, levkopenija, mielosupresija*, nevtropenija, trombocitopenija
English: Doses subsequent to initial dose should be adjusted if neutrophil count less than 500 cells/mm occurs for more than 5 days or is associated with fever or infection, if platelet count less than 25,000 cells/mm occurs, if any grade 3 or 4 toxicity develops or if renal clearance is less than 50 ml/min.
Slovenian: Odmerke, ki sledijo začetnemu odmerku, je treba prilagoditi, če je število nevtrofilcev pod 500 celic/mm3 več kot 5 dni ali se pojavita tudi zvišana telesna temperatura ali okužba, če je število trombocitov pod 25.000 celic/mm3, če se pojavi kateri od neželenih učinkov 3. ali 4. stopnje toksičnosti ali če je ledvični očistek nižji od 50 ml/min.
English: Etoposide is excreted in human milk.
Slovenian: Etopozid se izloča v materino mleko.
English: There is the potential for serious adverse reactions in nursing infants from VEPESID and associated names.
Slovenian: Obstaja možnost resnih neželenih učinkov, ki jih zdravilo VEPESID in povezana imena lahko povzroči pri dojenem otroku.
English: Historically, preclinical species have been more sensitive compared to humans towards cytotoxic agents.
Slovenian: Vrste iz predkliničnih študij so bile v preteklosti bolj občutljive na citotoksične učinkovine kot ljudje.
English: [To be completed nationally]
Slovenian: [Izpolni država članica.]
English: The usual dose is 100 to 200 mg/m2 body surface area, daily for 5 days in a row or 200 mg/m2 body surface area on days 1, 3
Slovenian: Običajni odmerek je 100 do 200 mg/m2 telesne površine dnevno, 5 dni zapored ali 200 mg/m2 telesne površine 1., 3. in 5. dan.
English: Contains sodium ethyl parahydroxybenzoate and sodium propyl parahydroxybenzoate (see leaflet for further information).
Slovenian: Vsebuje natrijev etilparahidroksibenzoat in natrijev propilparahidroksibenzoat (za nadaljnje informacije glejte navodilo za uporabo).
English: In general etoposide can cause fetal harm when administered to pregnant women.
Slovenian: Etopozid lahko škoduje plodu, če ga dajemo nosečnici.
English: - if you are taking warfarin (a medicine used to prevent blood clots from forming).
Slovenian: - Če jemljete varfarin (zdravilo, ki preprečuje nastanek krvnih strdkov).
English: In clinical studies involving etoposide, episodes of hypertension have been reported.
Slovenian: V kliničnih študijah, ki so vključevale etopozid, so poročali o epizodah visokega krvnega tlaka.
English: [See Annex 1 - To be completed nationally]
Slovenian: [glejte Prilogo I - izpolni država članica]
English: As etoposide may decrease male fertility, preservation of sperm may be considered for the purpose of later fatherhood (see section 4.6).
Slovenian: Etopozid lahko zmanjša plodnost pri moških, zato je, zaradi možnosti kasnejšega očetovstva, priporočljiv odvzem in hramba sperme (glejte poglavje 4.6).
English: Myelosuppression is most often dose-limiting.
Slovenian: Mielosupresija je neželeni učinek, ki najpogosteje omejuje nadaljnje odmerjanje.
English: After either intravenous infusion or oral capsule administration, the Cmax and AUC values exhibit marked intra- and inter-subject variability.
Slovenian: Tako po intravenski kot po peroralni uporabi je opaziti izrazito variabilnost Cmax in AUC tako pri posamezniku kot med posameznimi bolniki.
English: Severe liver, kidney or heart damage from a condition called tumour lysis syndrome, caused by harmful amounts of substances from the cancer cells getting into the blood stream, has been seen sometimes when VEPESID is taken along with other drugs used to treat cancer.
Slovenian: Ob jemanju zdravila VEPESID skupaj z drugimi zdravili za zdravljenje raka so včasih opazili hudo okvaro jeter, ledvic ali srca, ki nastopi zaradi zapleta, imenovanega sindrom tumorske lize, ki ga povzroči sproščanje škodljivih količin snovi iz rakavih celic v krvni obtok.
English: Patients should not begin a new cycle of treatment with VEPESID and associated names if the neutrophil count is less than 1,500 cells/mm or the platelet count is less than 100,000 cells/mm unless caused by malignant disease.
Slovenian: Bolniki ne smejo pričeti z novim ciklom zdravljenja z zdravilom VEPESID in povezana imena, če je število nevtrofilcev pod 1.500 celic/mm3 ali število trombocitov pod 100.000 celic/mm3, razen v primeru, ko je število celic zmanjšano zaradi maligne bolezni.
English: In addition the dose should be adjusted in case of occurrence of fever, infections, or at a thrombocyte count below 25,000 cells/mm3, which is not caused by the disease.
Slovenian: Poleg tega je treba odmerek prilagoditi, če se pojavijo zvišana telesna temperatura, okužbe ali če je število trombocitov nižje od 25.000 celic/mm3 , razen v primeru, ko je število celic zmanjšano zaradi same bolezni.
English: No evidence exists for any other differences in etoposide metabolism and excretion after administration of oral capsules as compared to intravenous infusion.
Slovenian: Prav tako ni dokazov o razlikah v presnovi in izločanju etopozida po peroralni uporabi kapsul in intravenski uporabi.
English: Dose limiting bone marrow suppression is the most significant toxicity associated with VEPESID and associated names therapy.
Slovenian: Mielosupresija, ki omejuje nadaljnje odmerjanje, je najpomembnejši toksični učinek zdravila VEPESID in povezana imena.
English: The roles of both administration schedules and cumulative doses of etoposide have been suggested, but have not been clearly defined.
Slovenian: Domneva se, da na nastanek sekundarne levkemije vplivata tako režim odmerjanja kot celotna količina prejetega etopozida, vendar pomen teh dveh dejavnikov ni bil jasno določen.
English: Other medicines and VEPESID and associated names
Slovenian: Druga zdravila in zdravilo VEPESID in povezana imena
English: Do not take VEPESID and associated names
Slovenian: Ne jemljite zdravila VEPESID in povezana imena
English: Given the mutagenic potential of etoposide, an effective contraception is required for both male and female patients during treatment and up to 6 months after ending treatment.
Slovenian: Glede na možno mutageno delovanje etopozida, morajo tako moški kot ženske uporabljati učinkovito kontracepcijo med zdravljenjem in do 6 mesecev po njem.
English: INFORMATION IN BRAILLE [To be completed nationally]
Slovenian: PODATKI V BRAILLOVI PISAVI [Izpolni država članica.]